CD27, A MEMBER OF THE TUMOR-NECROSIS-FACTOR RECEPTOR SUPERFAMILY, ACTIVATES NF-KB AND STRESS-ACTIVATED PROTEIN KINASE C-JUN N-TERMINAL KINASE VIA TRAF2, TRAF5, AND NF-KB-INDUCING KINASE/
H. Akiba et al., CD27, A MEMBER OF THE TUMOR-NECROSIS-FACTOR RECEPTOR SUPERFAMILY, ACTIVATES NF-KB AND STRESS-ACTIVATED PROTEIN KINASE C-JUN N-TERMINAL KINASE VIA TRAF2, TRAF5, AND NF-KB-INDUCING KINASE/, The Journal of biological chemistry, 273(21), 1998, pp. 13353-13358
CD27 is a member of the tumor necrosis factor (TNF) receptor superfami
ly and is expressed on T, B, and NK cells. The signal via CD27 plays p
ivotal roles in T-T and T-B cell interactions. Here we demonstrate tha
t overexpression of CD27 activates NF-kappa B and stress-activated pro
tein kinase (SAPK)/c-Jun N-terminal kinase (JNK). Deletion analysis of
the cytoplasmic domain of CD27 revealed that the C-terminal PIQEDYR m
otif was indispensable for both NF-kappa B and SAPK/JNK activation and
was also required for the interaction with TNF receptor-associated fa
ctor (TRAF) 2 and TRAF5, both of which have been implicated in NF-kapp
a B activation by members of the TNF-R superfamily. Co-transfection of
a dominant negative TRAF2 or TRAF5 blocked NF-kappa B and SAPK/JNK ac
tivation induced by CD27. Recently, a TRAF2-interacting kinase has bee
n identified, termed NF-kappa B-inducing kinase (NIK). A kinase-inacti
ve mutant NIK blocked CD27-, TRAF2-, and TRAF5-mediated NF-kappa B and
SAPK/JNK activation. These results indicate that TRAF2 and TRAF5 are
involved in NF-kappa B and SAPK/JNK JNK activation by CD27, and MK is
a common downstream kinase of TRAF2 and TRAF5 for NF-kappa B and SAPK/
JNK activation.